{
    "clinical_study": {
        "@rank": "66968", 
        "arm_group": {
            "arm_group_label": "1", 
            "description": "Furosemide-Fludrocortisone-Test and Ammonium chloride-Loading Test will be performed in renal stone patients."
        }, 
        "biospec_descr": {
            "textblock": "Blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The V-ATPase proton pump on the luminal membrane of \u03b1-intercalated cells is critical for\n      urinary acidification. To study the impact of polymorphisms in the ATP6V1 gene on\n      acidification in humans in vivo patients with nephrolithiasis will be enrolled in our renal\n      stone registry database and will undergo an intensive metabolic investigation. Exons of the\n      ATP6V1 gene will be sequenced and urinary acidification will be assessed."
        }, 
        "brief_title": "Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acidosis, Renal Tubular", 
            "Nephrolithiasis", 
            "Vacuolar Proton-Translocating ATPases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acidosis", 
                "Acidosis, Renal Tubular", 
                "Nephrolithiasis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  one or more episodes of nephrolithiasis\n\n        Exclusion Criteria:\n\n          -  absence of informed consent\n\n          -  all conditions affecting renal acidification\n\n          -  pregnancy\n\n          -  nursing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients suffered from at least one kidney stone episode."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01690039", 
            "org_study_id": "090/12"
        }, 
        "intervention": {
            "arm_group_label": "1", 
            "description": "The presence of a lack of urinary acidification will be assessed by an appropriate test in all patients.", 
            "intervention_name": "Furosemide-Fludrocortisone-Test (test for urinary acidification)", 
            "intervention_type": "Drug", 
            "other_name": "Application of Furosemide (Lasix\u00ae ) and Fludrocortisone (Florinef\u00ae)"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Fludrocortisone", 
                "Furosemide"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "renal tubular acidosis", 
            "V-ATPase", 
            "kidney stones"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "link": {
            "description": "Institution homepage", 
            "url": "http://www.nephrologie.insel.ch/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bern", 
                    "country": "Switzerland", 
                    "zip": "3010"
                }, 
                "name": "Department of Nephrology and Hypertension, Bern University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Fuster Daniel, Attending physician Nephrology", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Nasser Dhayat, Resident Nephrology", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Clinical Study About the Influence of Polymorphisms in the ATP6V1 Gene of the Vacuolar-type H+-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis in Patients With Recurrent Nephrolithiasis.", 
        "overall_contact": {
            "email": "daniel.fuster@ibmm.unibe.ch", 
            "last_name": "Daniel Fuster, Attending physician Nephrology", 
            "phone": "++41 (0)31 631 37 49"
        }, 
        "overall_contact_backup": {
            "email": "nasser.dhayat@insel.ch", 
            "last_name": "Nasser Dhayat, Resident Nephrology", 
            "phone": "++41 (0)31 632 31 44"
        }, 
        "overall_official": {
            "affiliation": "Department of Nephrology and Hypertension, Bern University Hospital", 
            "last_name": "Daniel Fuster, Attending physician Nephrology", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "capability of urinary acidification", 
            "safety_issue": "No", 
            "time_frame": "five to six hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01690039"
        }, 
        "responsible_party": {
            "name_title": "PD Dr. med. Daniel Fuster", 
            "organization": "University of Bern, Departement of Nephrology and Hypertension"
        }, 
        "secondary_outcome": {
            "measure": "polymorphisms in the ATP6V1 gene", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "University Hospital Inselspital, Berne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Inselspital, Berne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}